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TCTEX1D2 mutations underlie Jeune asphyxiating
thoracic dystrophy with impaired retrograde
intraﬂagellar transport
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The analysis of individuals with ciliary chondrodysplasias can shed light on sensitive
mechanisms controlling ciliogenesis and cell signalling that are essential to embryonic
development and survival. Here we identify TCTEX1D2 mutations causing Jeune asphyxiating
thoracic dystrophy with partially penetrant inheritance. Loss of TCTEX1D2 impairs retrograde
intraﬂagellar transport (IFT) in humans and the protist Chlamydomonas, accompanied by
destabilization of the retrograde IFT dynein motor. We thus deﬁne TCTEX1D2 as an integral
component of the evolutionarily conserved retrograde IFTmachinery. In complex with several
IFT dynein light chains, it is required for correct vertebrate skeletal formation but may be
functionally redundant under certain conditions.
DOI: 10.1038/ncomms8074 OPEN
1 Genetics and Genomic Medicine Programme, University College London (UCL), Institute of Child Health, 30 Guilford Street, London WC1N 1EH, UK.
2 Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands. 3 Radboud Institute for Molecular Life Sciences,
Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands. 4 Center for Pediatrics and Adolescent Medicine, University Hospital Freiburg,
Mathildenstrasse 1, 79112 Freiburg, Germany. 5 Department of Cell and Developmental Biology, University of Massachusetts Medical School, Worcester,
Massachusetts 01655, USA. 6 Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland 4072, Australia. 7 INSERM UMR_1163,
De´partement de ge´ne´tique, Institut Imagine, Universite´ Paris Descartes Sorbonne Paris Cite´, Hoˆpital Necker-Enfants Malades, Assistance Publique-Hoˆpitaux
de Paris, Paris 75015, France. 8Division of Experimental Ophthalmology and Medical Proteome Center, Center of Ophthalmology, University of Tu¨bingen,
Tu¨bingen 72074, Germany. 9 Plateforme de Bioinformatique, Institut Imagine, Universite´ Paris Descartes, Paris 75015, France. 10 Departments of Orthopaedic
Surgery and Human Genetics, David Geffen School of Medicine at UCLA, Los Angeles 90095, California, USA. 11 Section of Ophthalmology and
Neuroscience, Leeds Institutes of Molecular Medicine, University of Leeds, Leeds LS9 7TF, UK. 12 Developmental Biology and Cancer Programme, University
College London (UCL), Institute of Child Health, 30 Guilford Street, London WC1N 1EH, UK. 13Medical Genetics Department, Istanbul Medical Faculty,
Istanbul University, 34093 Istanbul, Turkey. 14Medical Genetics Department, Koc University School of Medicine, 34010 Istanbul, Turkey. 15 Department of
Molecular Biology and Biophysics and Institute for Systems Genomics, University of Connecticut Health Center, Farmington, Connecticut 06030, USA.
16 Centre for Translational Genomics-GOSgene, UCL Institute of Child Health, London WC1N 1EH, UK. 17 Department of Pediatrics, College of Medicine and
Health Sciences, United Arab Emirates University, PO Box 17666, Al Ain, United Arab Emirates. * These authors contributed equally to this work. ** These
authors jointly supervised the work. wA full list of consortium members appears at the end of the paper. Correspondence and requests for materials should be
addressed to H.M.M. (email: h.mitchison@ucl.ac.uk)
NATURE COMMUNICATIONS | 6:7074 | DOI: 10.1038/ncomms8074 |www.nature.com/naturecommunications 1
& 2015 Macmillan Publishers Limited. All rights reserved.
T
he malfunction of primary cilia, conserved signalling
organelles present on the surface of most cells, has
emerged as the cause of a growing number of severe
congenital developmental defects1,2. Intraﬂagellar transport
(IFT), a highly conserved process required for ciliary growth
and signalling, is powered by motors attached to IFT complexes
A and B. The kinesin-2 motor transports cargo along ciliary
microtubules towards the ciliary tip (anterograde IFT). IFT
complexes and other cargo are returned to the base of the cilium
(retrograde IFT) by a specialized cytoplasmic dynein3, termed
dynein 2 in vertebrates and dynein 1b in Chlamydomonas;
(hereafter referred to as ‘IFT dynein’). Chlamydomonas has
been a key organism for elucidating the molecular and
mechanistic basis of IFT. The known subunits of
Chlamydomonas IFT dynein are the homodimer-forming heavy
chain DHC1b, intermediate chains D1bIC1 and D1bIC2 (also
known as FAP163 and FAP133, respectively4), light-intermediate
chain D1bLIC and the light-chain LC8. Human IFT dynein
contains the homologues of these proteins, DYNC2H1, WDR60,
WDR34, DYNC2LI1 and DYNLL1/DYNLL2 (both of which are
LC8 homologues), and probably additional subunits4–10.
However, the regulation, cargo interactions and exact
composition of IFT dynein have remained relatively elusive.
Primary cilia and IFT are required for vertebrate hedgehog
signalling, an important regulator of skeletogenesis11. Mutations
in several IFT dynein components cause short-rib polydactyly
syndromes (SRPS) and Jeune asphyxiating thoracic dystrophy
(JATD; Jeune syndrome), a group of autosomal recessively
inherited, genetically heterogeneous ciliary chondrodysplasias
with overlapping phenotypic features12–16. The spectrum
of disease phenotypes varies in affected individuals but
hallmarks include short ribs and narrow thorax, short limbs,
with sporadic polydactyly and extraskeletal disease including
kidney, liver, eye, heart and brain defects. The underlying
genetic basis of these skeletal ciliopathies also overlaps,
with JATD at the milder end of the JATD/SRPS disease
spectrum17. To date, mutations in 10 genes have been
shown to cause Jeune syndrome, eight leading to classic JATD
with ciliogenesis defects due to IFT dysfunction; these
encode heavy and intermediate IFT dynein subunits
DYNC2H1, WDR34 and WDR60 (refs 12–16), IFT complex B
components IFT80 and IFT172 (refs 18,20), and IFT complex A
components WDR19/IFT144, TTC21B/IFT139 and IFT140
(refs 21–23). Two encode the centriole-associated proteins
CEP120 and CSPP1 (Jeune variants), which are important for
ciliary assembly or function19,24. Disease-causing mutations are
considered hypomorphic since no individuals with SRPS or JATD
were previously shown to carry biallelic loss-of-function
mutations13,17, and homozygosity for ‘null’ alleles is embryonic
lethal in mouse models around midgestation25,26.
Here we report biallelic loss-of-function mutations causing
JATD in the gene encoding TCTEX1D2, an IFT dynein light
chain distinct from DYNLL1/DYNLL2 (LC8). Unusually for the
SRPS/JATD spectrum, affected individuals all carry biallelic ‘null’
alleles where complete loss of protein function is predicted.
Furthermore, the disease phenotype appears incompletely
penetrant. Afﬁnity proteomics indicates that TCTEX1D2/Tctex2b
is an integral component of IFT dynein. We demonstrate a
retrograde IFT defect in TCTEX1D2-deﬁcient human ﬁbroblasts
and Tctex2b-deﬁcient Chlamydomonas cells, and ﬁnd that
IFT dynein is partially destabilized by loss of Tctex2b in
Chlamydomonas. Compared with mutations in other IFT
dynein components, TCTEX1D2/Tctex2b loss in human,
zebraﬁsh and Chlamydomonas has a modest effect on retrograde
IFT, likely explaining the partially penetrant nature of human
TCTEX1D2 mutations.
Results
Variants in TCTEX1D2 are associated with JATD. Whole-
exome sequencing of 69 individuals from 60 families clinically
diagnosed with JATD identiﬁed a homozygous consensus splice
variant (c.113þ 2C4G) in TCTEX1D2 (NM_152773.4, encoding a
dynein light chain) in individual UCL82 II.1 from a
consanguineous Turkish family (Supplementary Fig. 1a).
Reverse transcription PCR (RT-PCR) on RNA derived from
ﬁbroblasts of UCL82 II.1 detected no TCTEX1D2 transcript, sug-
gesting nonsense-mediated decay (NMD) of the mutant transcript
(Supplementary Fig. 2a). All primers used for human genetic
analysis are listed in Supplementary Table 1. Exome copy number
variant analysis revealed a 410-kb homozygous deletion in two
affected siblings (UCL4 II.6 and II.8) from a consanguineous
Arabic family that removes exon 1–2 of TCTEX1D2 including the
start codon, indicating a complete loss-of-function allele
(c.(?_ 142)_247þ ?del) (Supplementary Fig. 3). No other likely
disease-causing variants in known JATD/SRPS-causing genes or
other known ciliary components were detected in these two sib-
lings. The deletion also removes exon 2–5 of neighbouring
TM4SF19 encoding a protein reportedly involved in pancreatic
development but unlikely to be involved in JATD (Supplementary
Fig. 3). Reverse transcription PCR on RNA derived from blood
lymphocytes of individuals UCL4 II.6 and II.8 detected no
TCTEX1D2 transcript, indicating likely NMD of the mutant
transcript (Supplementary Fig. 2b), and no transcripts initiated at
the TM4SF19 start codon continuing into TCTEX1D2 downstream
of the deletion either. Analysis of a further 154 JATD/SRPS exomes
and Sanger sequencing of TCTEX1D2 in 69 additional JATD/SRPS
cases, previously excluded for mutations in known JATD and SRPS
genes, detected compound-heterozygous variants in TCTEX1D2 in
individual INS II.1 from a non-consanguineous French family
comprising a nonsense (c.262C4T; p.Arg88*) and a deletion-
insertion frameshift alteration (c.100delinsCT; p.Val34Leufs*12;
Supplementary Fig. 1b).
The TCTEX1D2 c.113þ 2C4G, c.262C4T and c.100delinsCT
variants are absent from the dbSNP, 1,000 Genomes and EVC
databases. The exon 1–2 deletion is absent from 500 exomes from
the UK10K project and 100 Bedouin control chromosomes
assessed by Sanger sequencing. The c.113þ 2C4G, c.262C4T
and c.100delinsCT variants segregated with the disease phenotype
in affected families as expected (Supplementary Fig. 1). However,
in family UCL4, the exon 1–2 deletion was detected not only in a
third affected individual who died at 2 months due to respiratory
insufﬁciency (UCL4 II.9) but also in two siblings (UCL4 II.1 and
II.5) for whom no clinical signs of JATD had been documented
(Fig. 1a and Supplementary Fig. 1c,d). When reassessed clinically
with a full X-ray exam, both UCL4 II.1 and II.5 showed mild
brachydactyly and slightly shortened lower limb distal segments;
they are both shorter in stature than their siblings that do not
carry the deletion, and one also had pectus carinatum as a child.
However, in contrast to the other ﬁve individuals documented
here as affected with typical clinical features of JATD (short
horizontal ribs, narrow thorax, trident acetabulum with spurs and
polydactyly; Fig. 2 and Table 1), no speciﬁc radiological signs of
JATD/SRPS were found in UCL4 II.1 and II.5 (Supplementary
Fig. 4). Thus, while their mild brachydactyly and short stature
could represent a very mild JATD phenotype, or radiological
diagnostic criteria for JATD might have been fulﬁlled in
childhood, we have no clinical or radiological proof for JATD.
Brachydactyly and short stature can occur with JATD but are not
speciﬁc for the condition. We therefore suggest that the
phenotype is not fully penetrant in this family, with the caveat
that we cannot deﬁnitively exclude an extremely mild expression
of the JATD phenotype in the two seemingly unaffected
individuals harbouring TCTEX1D2 mutations.
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We examined this further by single-nucleotide polymorphism-
based genome-wide linkage analysis in all members of UCL4. A
high penetrance recessive model coding UCL4 II.1 and II.5 as
unknown identiﬁed ﬁve homozygous linked regions all with a
logarithm of odds (LOD) score of 2.9, with TCTEX1D2 in the
second largest interval (Supplementary Table 2). Cross-reference
to the exome-sequencing data detected the TCTEX1D2 deletion
and just one other homozygous variant shared between UCL4 II.6
and II.8 in these intervals. The latter was in an untranslated
pseudogene TBC1D3P2 with a minor allele frequency of 1 in 500
in our in-house control database, suggesting it is not causative for
JATD. Considering UCL4 II.1 and II.5 as affected under a
reduced penetrance model (penetrance set at 0.6) generated three
linked regions including one with a LOD score 3.9 across
TCTEX1D2, with no homozygous variants shared between UCL4
II.6 and II.8 in the other intervals (Supplementary Table 3).
Considering UCL4 II.1 and II.5 as unaffected found no linkage to
homozygous variants shared between UCL4 II.6 and II.8 except
the TBC1D3P2 pseudogene variant (LOD score 2.9;
Supplementary Table 4). Finally, considering UCL4 II.1 and II.5
as affected under the high penetrance model identiﬁed just one
linked region, a 9.4-Mb locus containing TCTEX1D2 with a LOD
score of 4.1 (Supplementary Table 5). Thus, along with the
expected segregation in two independent families, linkage
modelling supports TCTEX1D2 mutations as disease-causing in
family UCL4.
Functional predictions and evidence of NMD suggest that all
four TCTEX1D2 variants identiﬁed are loss-of-function muta-
tions affecting the conserved TCTEX1 domain of the protein
(Fig. 1b). The questionable disease status in individuals UCL4 II.1
and II.5 suggests incomplete penetrance in this family, an
inheritance pattern not previously described for JATD.
Knockdown of tctex1d2 causes a typical ciliopathy phenotype.
TCTEX1D2 function was not previously investigated in verte-
brates and we tested for potential redundancy of the orthologous
gene in zebraﬁsh using oligonucleotide antisense morpholinos to
abrogate transcription. Morpholino oligomers have been used
widely to provide models for Jeune syndrome by transiently
knocking down the expression of the orthologous zebraﬁsh
genes18–20. This approach has been criticized for its inability to
reliably discriminate between speciﬁc and non-speciﬁc effects
such as developmental delay and cardiac oedema27,28. To increase
reliability, we established that human (NP_689986.2) and
zebraﬁsh (XP_685487.3) TCTEX1D2 proteins are highly
homologous, being 60% identical at 80% BLAST coverage. We
separately tested two different splice-blocking morpholinos and
focussed on phenotypic features described in JATD zebraﬁsh
mutants as well as morphants29–33.
Both morpholinos yielded identical results, producing a dose-
dependent typical ciliopathy phenotype18,20, with ventrally
curved body axis, hydrocephalus, abnormal otoliths and small
eyes (Fig. 3a–h). Loss of transcript was conﬁrmed by RT–PCR
(Supplementary Fig. 5 and Supplementary Table 1). The few
embryos surviving to 4 days post fertilization displayed severe
generalized oedema and pronephric cysts (Fig. 3c,g). Embryos
also showed defects of the craniofacial cartilage as visualized by
alcian blue staining (Fig. 3i,j,m,n), which were comparable to
those observed in other ciliary chondrodysplasia zebraﬁsh models
such as ift80, ift172 and cspp1 (refs 18–20). Immunoﬂuorescence
analysis revealed shorter cilia in the pronephric duct at 24 h post
fertilization (h.p.f.) in tctex1d2morphant embryos compared with
controls (Fig. 3k,o,l,p); however, this difference was no longer
observed at 48 h.p.f. (not shown). This could reﬂect delayed
ciliogenesis in the morphants or could result from general mild
developmental delay. Cilia in the neural tube appeared normal
(Supplementary Fig. 6).
Loss of TCTEX1D2 causes a retrograde IFT defect. We pro-
ceeded to investigate skin ﬁbroblasts from individual UCL82 II.1
for defects in cilia architecture and IFT disturbance. While the
percentage of ciliated cells was modest but signiﬁcantly lower for
TCTEX1D2 mutant ﬁbroblasts compared with controls (Fig. 4e),
no signiﬁcant difference in ciliary length was observed after 24-h
serum starvation, in contrast to the cilia shortening reported in
individuals with mutations in other JATD/SRPS genes12,19
(Fig. 4f). However, there was marked accumulation of the
IFT-particle protein IFT88 in B35% of the ciliary tips of
TCTEX1D2-deﬁcient ﬁbroblasts, compared with o10% of control
ﬁbroblasts (Fig. 4a–d). Cells from an individual previously
reported to carry DYNC2H1 mutations34 showed a very similar
pattern, which indicates a retrograde IFT defect (Fig. 4d).
Chlamydomonas Tctex2b is a light chain of IFT dynein. We
further investigated the role in IFT of Tctex2b, the Chlamydo-
monas homologue of TCTEX1D2 (49% identical at 80% BLAST
coverage; human to Chlamydomonas reciprocal best match
BLAST 9e 36). To determine whether Tctex2b is a subunit of
IFT dynein in Chlamydomonas, we used a new strain expressing
D1bIC2 (homologue of human IFT dynein intermediate chain
WDR34) fused to the haemagglutin-epitope tag (HA). This was
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Figure 1 | TCTEX1D2 deletion in UCL4 and location of identiﬁed variants
in TCTEX1D2 protein structure. (a) The absence of TCTEX1D2 exon 1 and 2
in family UCL4 is visualized by PCR of genomic DNA samples from
members of the UCL4 pedigree. TCTEX1D2 exon 4 primers verify the
presence of the gene in samples, but TCTEX1D2 exon 2 primers do not
amplify in some individuals. Children carrying the homozygous exon 1–2
TCTEX1D2 deletion are marked in black (diagnosed with JATD) or grey (two
siblings who were not diagnosed with JATD). The strikethrough indicates
death at 2 months of age; double line indicates consanguineous marriage.
See also Supplementary Fig. 1. (b) Human TCTEX1D2 (shown above, white
boxes indicate untranslated regions (UTR)) consists of ﬁve exons encoding
a 142 amino-acid protein (shown below) with a C-terminal TCTEX1 domain
(blue box). The location of the four identiﬁed TCTEX1D2 mutations is shown
in the gene (above). Their corresponding location in the protein (below)
shows the TCTEX1 domain will be at least partially lost for all variants
identiﬁed in individuals with JATD.
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generated by transforming an insertional mutant defective for
D1bIC2 (dic5-1; Hou et al., manuscript in preparation) with
C-terminal HA-tagged D1bIC2. dic5-1 cells have a severe ﬂagellar
assembly defect that is fully rescued by HA-tagged D1bIC2
(Supplementary Fig. 7), indicating its functional incorporation
into IFT dynein. D1bIC2-HA has a normal distribution in the
cell, is expressed in ﬂagella at approximately normal levels and
sediments normally as part of a complex when the ﬂagellar
membrane-plus-matrix is fractionated on sucrose gradients
(Supplementary Fig. 7). Therefore, D1bIC2-HA behaves like wild-
type D1bIC2 at all levels examined.
We used anti-HA antibody-conjugated beads to immuno-
precipitate D1bIC2-HA protein from the membrane-plus-matrix
fraction of isolated steady-state (that is, non-assembling) ﬂagella
of the D1bIC2-HA strain. SDS–polyacrylamide gel electro-
phoresis (SDS–PAGE) detected bands at BMr 90,000 and
15,000 in the D1bIC2-HA immunoprecipitate that were absent
from the wild-type control (Fig. 5a). Mass spectrometry of excised
bands identiﬁed several proteins speciﬁc for the D1bIC2-HA
sample, including D1bIC1 (homologue of H.s. WDR60), Tctex2b,
Tctex1 (homologous to both H.s. DYNLT1 and DYNLT3) and
LC8 (homologous to both H.s. DYNLL1 and DYNLL2). LC7a
(homologue of H.s. DYNLRB1 and DYNLRB2) was identiﬁed by
nine peptides in the D1bIC2-HA sample and two peptides in the
wild-type control. Western blotting conﬁrmed that D1bIC1,
Tctex2b, Tctex1 and LC8 were speciﬁc for the D1bIC2-HA
sample (Fig. 5b–e), and also identiﬁed LC7b (also a homologue of
H.s. DYNLRB1 and DYNLRB2) whose peptides were not detected
in the immunoprecipitate because it migrated below the
excised slice (Fig. 5c). Moreover, all detectable D1bIC1, Tctex2b
and Tctex1 were co-immunoprecipitated from the fraction
(Fig. 5b–d). About one-half of the LC7b, about one-quarter of
the DHC1b, D1bLIC and LC8, and trace amounts of FLA10 (a
kinesin-2 heavy chain) and several IFT-particle proteins also were
co-immunoprecipitated with D1bIC2 (Fig. 5b–e).
Tctex2b and Tctex1 have not previously been shown to be
associated with IFT dynein in Chlamydomonas, but they are
known subunits of the axonemal inner arm dynein I1/f, which is
involved in ﬂagellar motility35. Dynein I1/f is present at very low
levels in the membrane-plus-matrix fraction of steady-state
ﬂagella36. Nevertheless, to be sure that the presence of Tctex2b
and Tctex1 in the D1bIC2-HA immunoprecipitate was not due to
contamination by dynein I1/f, we probed blots of the unbound
and bound membrane-plus-matrix with an antibody to IC140, an
I1/f intermediate chain37, and found no IC140 in either the
unbound or bound fractions of either the wild-type or mutant
extracts. We also probed for p28, a subunit common to several
other inner arm dyneins and previously found in the membrane-
plus-matrix fraction of steady-state ﬂagella36. We readily detected
p28 in the unbound fractions, but not in the bound fractions,
indicating that the bound fractions were not contaminated by
these other inner arm dyneins (Fig. 5e). We conclude that
Tctex2b and Tctex1 are novel components of Chlamydomonas
IFT dynein. These results also show that the light chains Tctex2b
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Figure 2 | Clinical features of subjects with TCTEX1D2 mutations. Affected individuals presented with narrow thorax due to shortened ribs
(a–c, UCL82 II.1; g, INS family II.1; j, UCL4 II.6), typical pelvis conﬁguration showing trident acetabulum with spurs (arrows) (d, UCL82 II.1; h, INS family II.1;
k, UCL4 II.6), polydactyly (e,f, UCL82 II.1; l, UCL4 II.6), shortened extremities (a,b, UCL82 II.1) and brachydactyly (i, INS family II.1, asterisks indicate toes).
UCL82 is shown at 38 days in a, c, d and f) and 5.5 yrs in b and e).
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and Tctex1, and intermediate chain D1bIC1 are more closely
associated with D1bIC2 than with the heavy and light-
intermediate chains DHC1b and D1bLIC. It is therefore likely
that D1bIC2, D1bIC1, Tctex1, Tctex2b and LC7b together with
LC8 form a discrete intermediate chain/light-chain complex
within IFT dynein.
Tctex2b is involved in retrograde IFT. With this evidence that
Tctex2b is a subunit of IFT dynein, we investigated whether loss
of Tctex2b affects retrograde IFT. We re-examined a Chlamy-
domonas Tctex2b null strain (here termed tctex2b)35 previously
shown to swim slower than wild-type cells owing to a defect in
inner arm dynein I1/f, but not examined for defects in retrograde
IFT. The tctex2b mutant has normal length ﬂagella at steady state,
but its rate of ﬂagellar assembly is about one-third less than that
of wild type (Fig. 6a). Differential interference contrast (DIC)
microscopy revealed that anterograde IFT velocity is normal, and
anterograde IFT frequency only slightly reduced (Fig. 6b,c).
However, retrograde IFT velocity is B50% reduced, and
retrograde IFT frequency is o25% that of wild type (Fig. 6b,c).
Therefore, loss of Tctex2b has a severe effect speciﬁcally on
retrograde IFT, indicating that Tctex2b is required for normal
retrograde IFT.
IFT dynein is destabilized in the absence of Tctex2b. To better
understand why retrograde IFT frequency and velocity are
reduced in the Chlamydomonas tctex2b null mutant, we com-
pared IFT dynein levels in wild-type and tctex2b whole-cell
lysates by western blotting (Fig. 6d). DHC1b, D1bIC2 and
D1bLIC were each reduced by B40–60% in the mutant cells
relative to wild type. These results strongly suggest that IFT
dynein is destabilized in the absence of Tctex2b, with resulting
degradation of the protein complex. In isolated tctex2b ﬂagella,
levels of DHC1b, D1bIC2 and D1bLIC were reduced even further
(Fig. 6e) to onlyB15–25% that of wild type. This likely accounts
for the reduced frequency of retrograde IFT in the mutant.
Western blotting also revealed that the mutant whole cells had
normal levels of IFT-particle proteins (Fig. 6d), but the mutant
ﬂagella had increased amounts of all IFT complex A and B
Table 1 | Summary of clinical ﬁndings in individuals with TCTEX1D2 mutations.
Family Ethnicity Consan-
guineous
Patient Mutation Clinical
diagnosis
Thorax Polydactyly Other
skeletal
features
Renal,
liver or
eye
phenotype
Other
remarks
UCL4 UAE
(Yemeni)
Yes II.6 Homozygous
deletion of
exon 1þ 2
JATD Short
horizontal
ribs, narrow
thorax
Foot Trident
acetabulum
with spurs
No Obesity with
hypertension, alive at
16 years, height 10.p.
II.8 Homozygous
deletion of
exon 1þ 2
JATD Short
horizontal
ribs, narrow
thorax
Hand and
foot
Trident
acetabulum
with spurs
No Prolonged
tracheostomy, PEG
tube, alive at 10
years, height o3.p,
on growth hormone
up to 5.p.
II.9 Homozygous
deletion of
exon 1þ 2
JATD Short
horizontal
ribs, narrow
thorax
Hand and
foot
Trident
acetabulum
with spurs
No Died aged 2 months
due to respiratory
failure
II.1 Homozygous
deletion of
exon 1þ 2
NA Normal as a
young adult
No Not evident as a
young adult
(only mild
brachydactyly
and limb
shortening)
No Height o3.p.
No X-ray
documentation
during childhood
performed
II.5 Homozygous
deletion of
exon 1þ 2
NA Normal as a
young adult.
Pectus
carinatum
reported as a
child
No Not evident as a
young adult
(only mild
brachydactyly
and limb
shortening)
No Height o3.p.
No X-ray
documentation
during childhood
performed
UCL82 Turkish Yes II.1 Homozygous
splice site
mutation
c.113þ 2C4G
JATD Short
horizontal
ribs, narrow
thorax
Hand and
foot
Trident
acetabulum with
spurs,
brachydactyly
No Height o3.p.
Alive aged 5.5 years
INS French No II.1 Comp.
heterozygous
c.262C4T,
p.Arg88*;
c.100delinsCT,
p.Val34Leufs*12
JATD Short
horizontal
ribs
No Trident
acetabulum with
spurs,
brachydactyly
No Height 25.-50. p.
Alive at 3 years
JATD, Jeune asphyxiating thoracic dystrophy; NA, not applicable; p, percentile.
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proteins examined (Fig. 6e). This is in agreement with the IFT88
accumulation in ﬁbroblast cilia from affected individual UCL82
II.1 (Fig. 4); both indicate a retrograde IFT defect. If nearly
normal amounts of IFT complexes A and B (apparently
assembled into larger IFT trains; Fig. 6b) are being moved by
fewer dynein motors, it could also explain why IFT velocity is
reduced in the mutant ﬂagella. In addition, since IFT dynein is
reduced much more in the mutant ﬂagella than in the cell body,
the IFT dynein lacking Tctex2b is likely to be imported less
efﬁciently into ﬂagella than is the complete IFT dynein.
TCTEX1D2 is a component of human IFT dynein. To conﬁrm
that TCTEX1D2 is part of human IFT dynein, we performed
afﬁnity proteomics after expressing SF-TAP (Streptavidin/FLAG
Tandem Afﬁnity Puriﬁcation)-tagged TCTEX1D2 in HEK293T
cells; cells expressing SF-TAP-RAF1 served as a control. We were
able to identify interactions of TCTEX1D2 with IFT dynein
intermediate chains WDR34 and WDR60, and light chains
DYNLT1, DYNLT3 and DYNLRB1 (Supplementary Table 7). No
peptides from cytoplasmic dynein 1 intermediate chains were
detected, ruling out possible contamination by that dynein. An
interaction between TCTEX1D2 and WDR60 was veriﬁed after
overexpression of Flag-tagged TCTEX1D2 and GFP-tagged
WDR60 in HEK293T cells (Supplementary Fig. 8). Identiﬁcation
of TCTEX1D2, DYNLT1, DYNLT3 and DYNLRB1 as part of the
human IFT dynein is consistent with our ﬁnding that the
homologous Tctex2b, Tctex1 and LC7b are part of IFT dynein in
Chlamydomonas, and provides independent evidence that IFT
dynein contains several different light chains. A model of IFT
dynein based on these ﬁndings is shown in Fig. 7.
Discussion
Here we report that TCTEX1D2/Tctex2b is a light chain of IFT
dynein in humans and Chlamydomonas, and show for the ﬁrst
time that it is essential for IFT dynein stability and normal
retrograde (tip-to-base) IFT. In zebraﬁsh, tctex1d2 gene silencing
suggests a role conserved across vertebrates. We show that
biallelic loss-of-function alleles in this gene in humans cause
JATD. In all affected individuals, we identiﬁed biallelic
TCTEX1D2 null alleles, which is in striking contrast to JATD
and SRPS individuals carrying mutations in other IFT dynein
genes such as DYNC2H1 (refs 15,16,34,38,39), WDR34 (refs
12,13), WDR60 (ref. 14) or in genes encoding IFT-A21 and IFT-
B18,20 components. These individuals usually carry at least one
missense allele with inheritance restricted to two such
hypomorphic alleles or one hypomorphic allele in combination
with a null mutation13,17,39. Biallelic null alleles also cause early
embryonic lethality in mouse IFT dynein knockouts25,26,40–42,
and complete loss of IFT dynein subunits was thus to date
considered incompatible with embryonic development beyond
midgestation. Our data suggest that TCTEX1D2 is an exception to
this dogma, since all but one child carrying TCTEX1D2 null
mutations survived beyond infancy.
The high survival rate could reﬂect a milder thorax phenotype
than in individuals with mutations in other IFT dynein genes
 Pronephros Pronephros
Acetylated tubulin + DAPI Acetylated tubulin + DAPI
Acetylated tubulin + DAPIAcetylated tubulin + DAPI
tctex1d2 moControl mo
100 μm 100 μm
100 μm
100 μm
100 μm
100 μm 100 μm 100 μm 100 μm 100 μm
Alcian blue Alcian blue
Alcian blueAlcian blue
50 μm
50 μm
100 μm
100 μm
50 μm
50 μm
Figure 3 | Knockdown of tctex1d2 in zebraﬁsh leads to a typical ciliopathy phenotype. Whole-mount light microscopy showing control morpholino
(mo)-injected embryos (a–d) and tctex1d2 morphants at 4 days post fertilization (e–h). Compared with controls, knockdown of tctex1d2 results in ventrally
curved body axis (a,e), small eyes (b,f), pronephric cysts (c,g) and otolith defects (d,h). Alcian blue staining of cartilage identiﬁes craniofacial cartilage
defects in tctexd2 morphants (m,n) compared with controls (i,j). Immunoﬂuorescence analysis after staining of cilia at 24 h.p.f. with anti-acetylated tubulin
antibody reveals shorter cilia in the pronephric duct of tctex1d2 morphants (o, magniﬁed in p) compared with control embryos (k, magniﬁed in l); however,
this difference was no longer evident at 48 h.p.f. (data not shown). Scale bars, 100mm (a–j,m,n) or 50mm (k,l,o,p).
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such as DYNC2H1, WDR34 and WDR60 (refs 12–15,34).
Similarly to individuals with mutations in the IFT dynein
heavy-chain gene DYNC2H1 (refs 15,34), individuals with
TCTEX1D2 mutations did not show signs of extraskeletal
disease; however, these phenotypes could still emerge with age.
Two siblings (UCL4 II.1 and II.5) carrying homozygous
TCTEX1D2 mutations did not show overt signs of JATD,
suggesting disease non-penetrance. Both are now young adults,
and it is possible that early JATD radiological features (handlebar
clavicles, trident acetabulum with spurs and cone-shaped
epiphyses) were missed because a full X-ray exam was only
performed in adulthood after we detected the unusual penetrance
pattern. However, in contrast to their three affected siblings, they
also do not exhibit polydactyly or shortened ribs. Although both
are short statured with mildly short digits and lower limbs, more
speciﬁc radiological signs of JATD/SRPS were not found.
Together, these clinical ﬁndings suggest a less essential role of
TCTEX1D2 in ciliary transport mechanisms compared with other
proteins mutated in JATD and SRPS. Cilia of human ﬁbroblasts
with TCTEX1D2 mutations and tctex1d2 zebraﬁsh morphants
lack gross structural defects, indicating a potentially non-essential
role in vertebrate ciliogenesis. Similarly, ﬂagella of the Chlamy-
domonas tctex2b null mutant are normal length at steady state,
whereas null mutants of IFT dynein subunits DHC1b or D1bLIC
have a severe short ﬂagellar phenotype43–45.
Our studies in Chlamydomonas provide insight into the
molecular mechanism underlying the milder phenotype. Loss of
Chlamydomonas Tctex2b causes IFT dynein instability and a
reduced amount of IFT dynein in ﬂagella; however, surprisingly,
the residual IFT dynein lacking Tctex2b retains enough
functionality to maintain full-length ﬂagella. Thus, it appears
that a key role of Tctex2b is to stabilize IFT dynein. The lower
level of IFT dynein is accompanied by reduced retrograde IFT
velocity and frequency, causing an accumulation of IFT-particle
proteins both in Chlamydomonas ﬂagella and skin ﬁbroblast cilia
from affected individual UCL82 II.1. That Chlamydomonas cells
tolerate some reduction of retrograde IFT is in agreement with
observations that the dhc1b temperature-sensitive mutants
dhc1b-3 and ﬂa24 have reduced amounts of IFT dynein and
reduced retrograde IFT at permissive temperature, yet still
assemble normal length ﬂagella46–48. In the case of the tctex2b
mutant, ﬂagella are formed more slowly than in wild-type cells,
probably reﬂecting slower recycling of IFT components.
The slower ﬂagellar assembly in the Chlamydomonas tctex2b
mutant, if recapitulated in vertebrates, might explain our
observation that tctex1d2 morphant zebraﬁsh embryos appeared
to have short cilia at 24 h.p.f. but normal length cilia at 48 h.p.f.
Interestingly, this ﬁnding, and the normal length cilia and ﬂagella
found in patient UCL82 II.1 ﬁbroblasts and the Chlamydomonas
tctex2b mutant, contrasts with a recent report that short
interfering RNA-mediated depletion of TCTEX1D2 in human
telomerase-immortalized retinal pigment epithelial (hTERT-
RPE1) cells resulted in longer cilia49. However, cilia length
changes, ranging from shorter, normal length or longer than
normal12,18,34, have been reported in cells from JATD patients
with a number of gene defects. Furthermore, WDR34 mutant
patient ﬁbroblasts have shortened cilia12, whereas WDR34 short
interfering RNA knockdown in hTERT-RPE1 results in longer
cilia49. Vertebrate cilia length changes arising from retrograde
IFT perturbations may thus be cell type speciﬁc or subject to
experimental variability. These changes are not necessarily
predictable, and therefore do not seem to provide a reliable
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Figure 4 | Loss of human TCTEX1D2 results in retrograde IFT defects. Immunoﬂuorescence analysis using confocal microscopy revealed an
accumulation of IFT88 at the ciliary tips in skin ﬁbroblasts from individual UCL82 II.1 compared with a control (a,b). The accumulation is comparable to that
previously reported in ﬁbroblast cilia from an individual with JATD caused by biallelic variants in DYNC2H1 (ref. 34) (c). IFT88 staining is shown in green,
anti-acetylated tubulin antibody (red) was used for visualization of the ciliary axoneme, anti-pericentrin antibody (white) marks the ciliary base; the IFT88
labeling also is shown separately in the lower panels. Scale bars, 5mm. (d) Fraction of cells with IFT88 accumulation at the ciliary tip, 100 cells analysed for
each condition. (e) The percentage of ciliated cells in the ﬁbroblast sample from individual UCL82 II.1 compared with control ﬁbroblasts as assessed by
counting the number of cilia stained with anti-acetylated tubulin antibody in relation to nuclei stained with DAPI (4,6-diamidino-2-phenylindole, blue
in a–c) in 10 random visual ﬁelds in ﬁve independent experiments each, revealing a very mild reduction in ciliation for the TCTEX1D2-deﬁcient cells. One
hundred cells were counted per experiment, represented by a single point per experiment. (f) No difference in cilia length between UCL82 II.1 and control
ﬁbroblasts was visualized using anti-acetylated tubulin antibody, 100 cells analysed for each condition. Statistical signiﬁcance in e and f was measured
using the Student’s t-test, asterisk indicates P value o0.05.
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measure, compared with the direct IFT measurements reported
here that include immunoﬂuorescence imaging of altered
localization of IFT cargos and DIC imaging of IFT velocity.
Although no difference in cilia length was observed in skin
ﬁbroblasts of JATD compared with control individuals in our
study, similar to the Chlamydomonas Tctex2b mutant, any delay
in cilia assembly could have severe consequences during
development if full-length cilia are required for proper
functioning of the hedgehog or other vertebrate ciliary
signalling pathways soon after onset of cilia formation. Since
retrograde IFT is critical for hedgehog signalling11,50, impaired
retrograde IFT even in full-length cilia could be expected to affect
skeletal development, as seen in the TCTEX1D2-mutated JATD
individuals.
The Chlamydomonas Tctex2b mutant swims B30% slower
than wild-type cells owing to defects in axonemal dyneins35.
However, a ciliary motility defect is not the cause of JATD,
because primary ciliary dyskinesia (PCD) patients with ciliary
motility defects do not have JATD symptoms, and multiciliated
cells bearing motile cilia are not present in the tissues affected in
JATD nor in their progenitor cells1. JATD is caused by defects in
primary cilia; primary cilia lack axonemal dyneins.
Proteomic analysis in Chlamydomonas and human cells
conﬁrmed Tctex2b/TCTEX1D2 as a component of IFT dynein
along with intermediate chains D1bIC2/WDR34 and D1bIC1/
WDR60, and a number of light chains. Immunoprecipitation of
Chlamydomonas IFT dynein not only identiﬁed Tctex2b but also
Tctex1 and LC7b as novel subunits of IFT dynein, indicating that
these light chains together with LC8, D1bIC2 and D1bIC1 likely
form a light-chain/intermediate chain complex within IFT
dynein, which also may contain subunits not detected by our
methods. Proteomics analysis of HEK293T proteins co-immuno-
precipitated with SF-TAP-tagged TCTEX1D2 likewise identiﬁed
DYNLT1 and DYNLT3 (human Tctex1), and additional light
chains in the LC8 and roadblock families (DYNLL2¼ LC8-type 2
and DYNLRB1¼DNLC2A). The light-chain pairs DYNLL1/
DYNLL2 and DYNLRB1/DYNLRB2 have a high sequence
identity of 93% and 77% respectively. This approach did not
identify any peptides speciﬁc for DYNLL1 or DYNLRB2, but one
peptide each was identiﬁed for DYNLL1/DYNLL2 and
DYNLRB1/DYNLRB2, which could have originated from either
of the two homologous proteins. Furthermore DYNLL1 was
previously conﬁrmed as a light chain of human IFT dynein13.
Therefore, we propose that these subunits are components of an
ancient, highly conserved intermediate chain/light-chain complex
within IFT dynein (Fig. 7). As such, these light chains are strong
candidates for harbouring novel mutations causing JATD.
Dynein complexes fall into two general types based on whether
they contain single or multiple heavy-chain motor units51. Those
with multiple motors all associate with a core group of accessory
proteins including WD-repeat intermediate chains and light
chains in the Dynll/LC8, Dynlt/Tctex1 and Dynlrb/LC7 classes
(axonemal outer dynein arms and inner arm I1/f also include
proteins related to TCTEX1D2/Tctex2, which form a distinct
subfamily within the Dynlt/Tctex1 group51). Our demonstration
that the IFT dynein includes a member of this subfamily suggests
that the presence of TCTEX1D2 is also a conserved deﬁning
feature of these multimotor dyneins, and raises the possibility that
canonical cytoplasmic dynein 1 might also associate with
members of this light chain type under certain circumstances52.
The possible disease non-penetrance in family UCL4 is of
clinical interest. Variable phenotypic severity is well documented
for JATD/SRPS even within families. However, never before to
the extent that individuals can appear clinically unaffected but
carry biallelic loss-of-function variants that cause documented
JATD/SRPS in other family members. Functional redundancy of
TCTEX1D2 with other proteins could explain this, if, for
example, other dynein light chains might in certain conditions
be able to compensate for its loss. Mice carrying Dynll1 mutations
showed possible functional redundancy of IFT dynein light
chains, whereby DYNLL2 may be able to function in place of
DYNLL1 (ref. 53). We looked at single-nucleotide polymorphism
haplotypes across dynein light-chain genes DYNLL1, DYNLL2
and TCTEX1 in individuals UCL4 II.1 and II.5 who carry the
TCTEX1D2 deletion but appear clinically unaffected. Both have
different haplotypes across TCTEX1 compared with their siblings
II.8 and II.9 who display a classical JATD phenotype, but whether
protective alleles could exist in compensatory genes is not clear
(Supplementary Fig. 9).
Alternatively, TCTEX1D2 loss could be attenuated by
individual-to-individual variation in the proteins with which
TCTEX1D2 normally interacts, or in other proteins involved in
IFT dynein stabilization or degradation. Modiﬁer alleles have
been debated as the underlying cause of the phenotypic variability
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Figure 5 | Tctex2b and Tctex1 are in an IFT dynein intermediate
chain/light-chain subcomplex with D1bIC2 and D1bIC1. (a) Flagellar
membrane-plus-matrix fractions from wild-type (WT) cells or cells
expressing D1bIC2-HA were incubated with anti-HA antibody-conjugated
beads. The proteins pulled down by the beads were separated by
SDS–PAGE and silver stained. One band (marked *) between 75 and
100 kDa and several bands around 15 kDa (marked ]) are speciﬁc for the
D1bIC2-HA sample. (b–d) Western blots conﬁrming that Tctex2b, Tctex1
and D1bIC1 are speciﬁcally co-precipitated with D1bIC2-HA. The unbound
and bound samples were probed with the indicated antibodies. In each
experiment, all of the D1bIC2-HA was immunoprecipitated from the
D1bIC2-HA sample; all of the D1bIC1 (b,d), Tctex1 (b) and Tctex2b (c) was
co-precipitated from the D1bIC2-HA sample. None of these proteins were
pulled down from the WT control. Some but not all of the DHC1b (d),
D1bLIC (b,d), LC7b (c) and LC8 (e) was co-precipitated from the
D1bIC2-HA samples; (d) also shows that only very small amounts of the
IFT-particle proteins or FLA10 were co-precipitated with D1bIC2-HA.
(e) Similar western blot showing that p28 was not co-precipitated with
D1bIC2-HA. In b, d and e, the ratio of unbound: bound protein loaded was
1:4; in c, the ratio was 1:2. All antibodies used for Chlamydomonas protein
analysis are listed in Supplementary Table 6.
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in ciliary chondrodysplasias13,23,34 and other ciliopathies such as
Bardet–Biedl, Joubert and Meckel syndromes; however, this has
remained a challenge to prove in human subjects54,55. Variable
penetrance in autosomal recessive conditions is still quite
unusual, one example being a common CFTR variant that
causes either disease or a normal phenotype depending on its
genetic context56.
It may be relevant that partial suppression of mutations in
genes encoding IFT-particle proteins has been observed
in Chlamydomonas and Tetrahymena57–59; this occurs in
association with stress, suggesting possible involvement of a
chaperone in stabilizing the incomplete IFT particle. Given that a
key role of Tctex2b is to stabilize IFT dynein, the presence or
absence of another protein such as a chaperone that helps
stabilize IFT dynein could determine whether or not a
developmental defect is observed in the absence of Tctex2b.
Interestingly, peptides derived from chaperones were abundant in
our proteomic analysis of TAP-tagged TCTEX1D2 from
HEK293T cells.
In summary, we have identiﬁed mutations associated with
a complete loss of TCTEX1D2 causing Jeune syndrome.
TCTEX1D2 mutations are a rare cause of disease affecting
o5% of cases in this study (three affected families identiﬁed after
screening of 4300 individuals with JATD/SRPS). There are
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subunits in tctex2b whole-cell lysates. Wild-type (A54-e18) and tctex2b whole-cell lysates were probed with antibodies to IFT dynein subunits and
IFT-particle proteins. DHC1b, D1bIC2 and D1bLIC are reduced in tctex2b whole-cell lysate. No signiﬁcant changes were detected for IFT proteins. The same
samples were probed for tubulin as loading control. (e) IFT dynein is greatly reduced in tctex2b ﬂagella. Wild-type (A54-e18) and tctex2b ﬂagella were
probed with antibodies to IFT dynein subunits and IFT-particle proteins. IFT dynein subunits DHC1b, D1bIC2 and D1bLIC are greatly reduced in tctex2b
ﬂagella. IFT-A protein IFT139 and IFT-B proteins IFT172 and IFT81 are increased in tctex2b ﬂagella, consistent with a retrograde IFT defect. The same
samples were probed for tubulin as loading control.
Dynein 2 (Hs) / Dynein 1b (Cr)
TCTEX1D2 (Hs)
TCTEX2b (Cr)
DYNLL1, DYNLL2 (Hs)
LC8 (Cr)
DYNLT1, DYNLT3 (Hs)
TCTEX1 (Cr)
DYNLRB1, ?DYNLRB2 (Hs)
LC7b, ?LC7a (Cr)
WDR34 (Hs)
D1blC2 (Cr)
WDR60 (Hs)
D1blC1 (Cr)
Figure 7 | Proposed model of IFT dynein composition in Homo sapiens
(Hs) and C. reinhardtii (Cr). Left, IFT dynein (dynein 2/1b) is composed of
dynein heavy chains (DYNC2H1(Hs)/DHC1b(Cr); shown in dark grey),
dynein light-intermediate chains (DYNC2LI1(Hs)/D1bLIC(Cr); shown in
light grey) and different dynein intermediate and light chains (coloured,
shown in detail on the right). Right, dynein intermediate chains
(WDR34(Hs)/D1bIC2(Cr) and WDR60(Hs)/D1bIC1(Cr)) interact with
different dynein light-chain subtypes, including TCTEX1D2(Hs)/
TCTEX2b(Cr). Question marks indicate LC7a and DYNLRB2 as unconﬁrmed
components suggested from our Chlamydomonas and human results.
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important implications for genetic counselling since individuals
carrying TCTEX1D2 mutations appear to have a higher survival
rate than individuals affected by mutations in other IFT dynein
components, and lack extraskeletal symptoms. In humans, ﬁsh
and Chlamydomonas, TCTEX1D2 mutations do not confer
changes in gross ciliary structure, but do impair the highly
conserved retrograde IFT machinery. Proteomic analysis provides
evidence that TCTEX1D2/Tctex2b is a component of an
intermediate chain/light-chain subcomplex within IFT dynein.
In Chlamydomonas, the retrograde IFT defect is associated with
instability of IFT dynein; motor stability may be the major role of
Tctex2b since the residual IFT dynein missing Tctex2b retains
some functionality. Our ﬁndings that IFT is impaired to a lesser
extent in TCTEX1D2/Tctex2b null cells than in cells carrying null
mutations in other IFT dynein components could explain, in part,
the apparently incomplete penetrance underlying TCTEX1D2
disease. This potentially has future clinical therapeutic implica-
tions, for example, if modulation of other components affecting
the IFT dynein system could be harnessed to attenuate the effects
of a lack of TCTEX1D2 function.
Methods
Patients. Inclusion criteria were the clinical diagnosis of JATD based on clinical
and radiological ﬁndings including short ribs with small/narrow thorax and small
ilia with acetabular spurs, handlebar clavicles and brachydactyly. All samples were
obtained with approval of the UCL-ICH/Great Ormond Street Hospital Research
Ethics Committee (08/H0713/82), South Yorkshire Research Ethics Committee
(11/H1310/1) and collaborating institutions with informed consent.
Human Sanger sequencing and PCR. Familial segregation in accordance with a
recessive inheritance pattern was conﬁrmed by Sanger sequencing of PCR
products ampliﬁed from genomic DNA samples of all available family members
(SourceBiosciences, Cambridge, UK). For family UCL4, fresh repeat samples were
collected for segregation analysis, indicating no chance of sampling error. For
RT–PCR, the Omniscript kit (Qiagen) was used to make cDNA from total RNA
isolated from lymphocytes or ﬁbroblasts of affected individuals and controls using
Trizol–chloroform extraction. PCR and RT–PCR primers used are listed in
Supplementary Table 1.
Western blotting. Uncropped images of all western blots are included in
Supplementary Fig. 10.
Constructs used in mammalian cells. Mouse WDR60 and human TCTEX1D2
cDNA were obtained from the University of Queensland’s SRC Microarray facility.
A sequence-veriﬁed SF-TAP-TCTEX1D2 construct (BC021177.2) containing a
double Streptavidin II and a single FLAG tag was kindly provided by Nicholas
Katsanis (Duke University, Durham, USA). WDR60 was cloned into the GFP-N1
vector by PCR ampliﬁcation, EcoRI/KpnI digestion and ligation. TCTEX1D2
cloned into a modiﬁed pCR3 vector for expression of FLAG-tagged proteins was a
kind gift from Dr Jo¨rg Heierhorst (St Vincent’s Institute of Medical Research,
Melbourne). The human tGFP-taggedWDR34 mammalian expression plasmid was
obtained from OriGene Technologies, Inc. (TrueORF clone RG204288).
Human cell culture. Human ﬁbroblasts obtained by skin biopsy from study
subjects and HEK293T cells (European Collection of Cell Cultures) were cultured
under standard conditions at 37 C and 5% CO2 in DMEM-F12 Glutamax medium
(Life Technologies) with 10% fetal bovine serum (Life Technologies).
Immunoﬂuorescence in mammalian cells and zebraﬁsh. Human ﬁbroblasts
were split onto glass coverslips and grown until conﬂuent. For ciliogenesis
experiments, cells were serum starved using cell medium without fetal bovine
serum for 20 h. For immunoﬂuorescence, cells were then ﬁxed in 4% paraf-
ormaldehyde (PFA) for 10min, washed ﬁve times with PBS, treated with 0.05%
Triton X-100/PBS for 2min, washed ﬁve times with PBS, blocked 1 h using 4% BSA
in PBS and then incubated with the primary antibody. These were mouse mono-
clonal anti-acetylated tubulin 1:1,000 (IgG2b, clone 6-11-b1, Sigma), mouse
monoclonal anti-pericentrin IgG1 1:200 (mAbcam 28144, Abcam) or rabbit
polyclonal anti-IFT88 1:100 (13967-1-AP, Proteintech) overnight at 4 C. Cells
were then washed again ﬁve times with PBS and incubated with the appropriate
secondary antibodies: goat anti mouseIgG1 Alexa Fluor 647, goat anti-mouse
IgG2b Alexa Fluor 568 or goat anti-rabbit Alexa Fluor 488. Glass slides were then
washed ﬁve times in PBS, incubated with 4,6-diamidino-2-phenylindole (Molecular
Probes, Invitrogen) for 5min to obtain nuclear stain, washed ﬁve times in PBS and
then mounted in Vectashield (Vector Laboratories). For zebraﬁsh immuno-
ﬂuorescence studies, embryos were ﬁxed at 24 h.p.f. in 4% PFA overnight, washed
ﬁve times in PBS containing 0.1% Triton X-100/PBS, incubated in 10% methanol
for 30min at  20 C, washed ﬁve times in PBS containing 0.1% Triton X-100 and
blocked with 5% BSA in PBS containing 0.1% Triton X-100 for 1 h. Embryos were
then incubated with the primary antibody mouse monoclonal anti-acetylated
tubulin 1:1,000 (IgG2b, clone 6-11-b1, Sigma) or mouse monoclonal anti-gamma
tubulin 1:250 (IgG1, Sigma) overnight at 4 C, washed ﬁve times in PBS containing
0.1% Triton X-100/PBS and then incubated with the appropriate secondary anti-
bodies: goat anti-mouse IgG1 Alexa Fluor 647 1:1,000 or goat anti-mouse IgG2b
Alexa Fluor 488 1:1,000 and 4,6-diamidino-2-phenylindole 1:25,000. All imaging
was performed using a Zeiss LSM710 confocal microscope.
Statistical analysis. Statistical analysis of cilia number and cilia length was per-
formed using Student’s t-test with statistical analysis performed using GraphPad
Prism.
Chlamydomonas cells and culture conditions. Chlamydomonas reinhardtii strain
137c (nit1, nit2, mtþ ) from the Chlamydomonas Resource Center (University of
Minnesota, St Paul, MN) was used as wild type. A54-e18 (nit1-1, ac17, sr1, mtþ ),
which is the parent of pf16-D2 (a double mutant of pf16 and tctex2b), and ‘pf16-D2
Resc. w/PF16,’ which is pf16-D2 rescued for the PF16 gene35,60, were from
Elizabeth Smith (Dartmouth College, NH). The dic5-1 insertional mutant was
generated by transforming g1 cells (nit1, NIT2, mtþ )61 with the 1.7-kb chimeric
aph70 0 gene cut by HindIII from the Hyg3 plasmid62, followed by backcrossing of a
transformant to wild-type cells. The D1bIC2-HA strain was generated by
transformation of dic5-1 with a gene encoding D1bIC2 with a C-terminal 3 HA
tag. Cells were grown in TAP medium63 or M medium I64 altered to have 0.0022M
KH2PO4 and 0.00171M K2HPO4; cultures were either aerated with 5% CO2 and
95% air or grown on 24-well plates.
Creation of DNA constructs for Chlamydomonas transformation. The wild-type
DIC5 gene was ampliﬁed by PCR from genomic DNA using primer pairs FAP133-
2 (50-TGTCCCGCTGCAGAGCAATG-30) and FAP133-3 (50-ACCCCG
CCTCCTTGTCCTTG-30). The blunt ends of the PCR product were modiﬁed by
A-tailing, that is, an extra A was added at the 30 ends of the product strands by Taq
polymerase. The modiﬁed PCR product was cloned into pGEM-T (Promega,
Madison, MI). To insert an HA tag into the DIC5 gene just before the stop codon,
primer pair FAP133-15 (50-GTAGAGTGGCAGTGCCGGC-30) and FAP133-16
(50-GCGTGAAGTTGCCGCGCA-30) was used to amplify the DIC5 gene and
vector. The PCR product was then ligated to the 3 HA fragment excised from
plasmid p3HA65 by SmaI.
Chlamydomonas immunoprecipitation and mass spectrometry. Flagella mem-
brane-plus-matrix fractions from wild-type and D1bIC2-HA cells were incubated
with the anti-HA afﬁnity matrix (Roche Diagnostics GmbH) overnight. The beads
were washed three times with HMEK buffer (30mM HEPES, pH 7.4, 5mM
MgSO4, 0.5mM EGTA and 25mM KCl) plus 0.01% NP-40. Protease Inhibitor
Cocktail for plant cell and tissue extracts (Sigma-Aldrich) was added to prevent
protein degradation. SDS–PAGE sample loading buffer was used to elute the
proteins from the matrix. Proteins in the bound fractions from wild-type and
D1bIC2-HA samples were then separated by SDS–PAGE and stained with Silver
Stain Plus (Bio-Rad). Gel regions of interest were excised and analysed by mass
spectrometry at the Proteomics and Mass Spectrometry Facility, University of
Massachusetts Medical School, and the Vermont Genetics Network Proteomics
Facility, University of Vermont66,67.
Flagellar regeneration and analysis of IFT. For DIC imaging of steady-state
ﬂagella and the subsequent analysis of IFT, live cells were immobilized in 1%
agarose and observed using an inverted microscope (Ti U; Nikon) equipped with
DIC optics59. To determine the kinetics of ﬂagellar regeneration, cells were
deﬂagellated by the pH-shock method68 and allowed to regrow ﬂagella under the
same conditions as before deﬂagellation. Aliquots of the cell suspensions were
removed at various times and ﬁxed with 1% glutaraldehyde. Images of the ﬁxed
cells were acquired with an AxioCam camera, AxioVision 3.1 software, and an
Axioskop 2 plus microscope (Zeiss). Flagellar lengths were measured using ImageJ
(http://rsb.info.nih.gov/ij/index.html). Images were processed using Adobe
Photoshop (Adobe Systems Incorporated, San Jose, CA).
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